Cervical Cancer

Despite increasing early detection of cervical cancer, in 2022, it is estimated that 14,100 women will be diagnosed with invasive cervical cancer in the United States. Of these women, an estimated 4,280 of them will die from the disease [1]. Over the years, the death rate due to cervical cancer has decreased significantly, and the...

The COVID-19 pandemic abruptly caused unexpected chaos all over the world. Healthcare was forced to quickly modify how patients were receiving care while at the same time attempting to manage the influx of sick patients, all with reduced staff. As a result, COVID-19 has impacted so many areas of medicine, including cervical cancer screening. The...

Among other problems, the COVID-19 pandemic has resulted in many missed medical visits for cervical cancer screening. As we continue to work through the pandemic, one approach is to use HPV self-sampling instead of cervical cytology, which requires a healthcare provider visit and pap smear. HPV self-sampling has already been implemented in some areas of...

Despite existing cervical cancer screening options, cervical cancer remains one of the most common cancers in women between the ages of 15 – 44 [1]. It is worth taking the time to understand cervical cancer screening disparities so that efforts can be made to rectify them.  Identifying Barriers to Cervical Cancer Screening A recent study...

The international prevalence of depression in patients with cervical cancer is high. This cross-sectional study, published in PLOS ONE, examines the factors associated with depression and a worse quality of life in patients with cervical cancer.  The study was conducted at a gynecologic oncology clinic affiliated with a university hospital in Thailand. A total of 200 patients...

Cervical cancer is the fourth most common cancer in women. According to data from the World Health Organization (WHO), approximately 311,000 women worldwide died from cervical cancer in 2018. Cervical cancer used to be the leading cause of cancer death for women in the United States too before the introduction of HPV vaccination [1]. In...

About two-thirds of older women fail to qualify for discontinuation of cervical cancer screening, according to a study published in Gynecologic Oncology. Jacqueline M. Mills, M.D., from the Boston University School of Medicine, and colleagues assessed eligibility for cervical cancer screening discontinuation based on current guidelines among 590,901 women aged 64 years old listed in a...

According to a study recently published in the Journal of Women’s Health, nearly three in four low-income women cite perceived substantial financial barriers to undergoing cervical cancer screening. Caitlin B. Biddell, from the University of North Carolina at Chapel Hill, and colleagues surveyed 702 low-income, uninsured, or publicly insured women (aged 25 to 64 years old)...

Global cervical cancer incidence and mortality rates have remained stable or are decreasing, according to a study published in Cancer. Shujuan Lin, from Zhejiang University School of Medicine in Hangzhou, China, and colleagues extracted data on global cervical cancer incidence and mortality in 2018 and analyzed their correlations with the Human Development Index. Temporal trends were...